EMBC - Embecta Corp. Stock Price, Fair Value and News

10.30USD-0.10 (-0.96%)Market Closed

Market Summary

USD10.30-0.10

Market Closed

-0.96%

EMBC Stock Price

View Fullscreen

EMBC RSI Chart

EMBC Valuation

Market Cap

593.1M

Price/Earnings (Trailing)

10.72

Price/Sales (Trailing)

0.53

EV/EBITDA

19.24

Price/Free Cashflow

-19.57

EMBC Price/Sales (Trailing)

EMBC Profitability

EBT Margin

5.69%

Return on Equity

10.05%

Return on Assets

4.54%

Free Cashflow Yield

-5.11%

EMBC Fundamentals

EMBC Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

0.58%

Rev. Growth (Qtr)

-1.63%

EMBC Earnings

Earnings (TTM)

55.3M

Earnings Growth (Yr)

-42.9%

Earnings Growth (Qtr)

235%

Breaking Down EMBC Revenue

Last 7 days

-3.0%

Last 30 days

-20.2%

Last 90 days

-40.5%

How does EMBC drawdown profile look like?

EMBC Financial Health

Current Ratio

2.2

Debt/Equity

2.89

Debt/Cashflow

EMBC Investor Care

Dividend Yield

1.46%

Dividend/Share (TTM)

0.15

Shares Dilution (1Y)

0.53%

Diluted EPS (TTM)

0.96

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.1B	1.1B	1.1B	1.1B
2022	1.2B	1.2B	1.1B	1.1B
2021	1.1B	1.1B	1.2B	1.2B
2020	0	0	1.1B	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Embecta Corp.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 04, 2024	kurdikar devdatt	sold (taxes)	-57,957	12.78	-4,535	president and ceo
Feb 12, 2024	melcher david f	bought	32,500	16.25	2,000	-
Feb 11, 2024	kurdikar devdatt	sold (taxes)	-279,103	16.26	-17,165	president and ceo
Feb 07, 2024	reidy christopher r	acquired	-	-	11,455	-
Feb 07, 2024	melcher david f	acquired	-	-	14,892	-
Feb 07, 2024	anderson carrie l	acquired	-	-	11,455	-
Feb 07, 2024	albritton david	acquired	-	-	11,455	-
Feb 07, 2024	prange karen	acquired	-	-	11,455	-
Feb 07, 2024	morris milton mayo	acquired	-	-	11,455	-
Feb 07, 2024	pomeroy claire	acquired	-	-	11,455	-

Which funds bought or sold EMBC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Allworth Financial LP	reduced	-8.02	-11,747	21,293	-%
Apr 25, 2024	Legacy Bridge, LLC	unchanged	-	-22.00	54.00	-%
Apr 25, 2024	Lindbrook Capital, LLC	reduced	-21.82	-7,136	8,652	-%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	unchanged	-	-84,917	199,090	-%
Apr 25, 2024	GHP Investment Advisors, Inc.	unchanged	-	-2,626	6,158	-%
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-1.84	-4,698,520	10,366,000	-%
Apr 25, 2024	Bogart Wealth, LLC	sold off	-100	-360	-	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	added	143	6,000	15,000	-%
Apr 25, 2024	NEW YORK STATE TEACHERS RETIREMENT SYSTEM	unchanged	-	-436,000	1,024,000	-%
Apr 25, 2024	NATIXIS ADVISORS, L.P.	sold off	-100	-578,000	-	-%

Are Funds Buying or Selling EMBC?

Are funds buying EMBC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EMBC

No. of Funds

Unveiling Embecta Corp.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	0.0%	0	SC 13G/A
Feb 13, 2024	vanguard group inc	12.20%	7,026,005	SC 13G/A
Feb 12, 2024	american century investment management inc	5.02%	2,888,207	SC 13G
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 30, 2024	river road asset management, llc	5.8%	3,310,749	SC 13G
Jan 23, 2024	state street corp	4.37%	2,517,076	SC 13G/A
Jan 22, 2024	integrated core strategies (us) llc	6.3%	3,621,084	SC 13G/A
Jan 22, 2024	blackrock inc.	16.4%	9,427,335	SC 13G/A
Dec 07, 2023	american century investment management inc	3.56%	2,039,405	SC 13G/A
Feb 10, 2023	state street corp	3.95%	2,255,474	SC 13G/A

Recent SEC filings of Embecta Corp.

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	3/A	Insider Trading
Apr 23, 2024	3/A	Insider Trading
Apr 08, 2024	4	Insider Trading
Apr 05, 2024	10-K/A	Annual Report
Mar 28, 2024	8-K	Current Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	4	Insider Trading
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	4	Insider Trading
Feb 12, 2024	SC 13G	Major Ownership Report

Peers (Alternatives to Embecta Corp.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.5B	40.1B	-5.27%	-1.83%	32.59	4.65	-8.12%	-17.45%
BDX	66.9B	19.5B	-6.10%	-12.08%	53.25	3.43	4.02%	-22.04%
ALGN	23.2B	3.9B	-5.77%	-2.75%	52.14	6.01	3.42%	23.09%
BAX	20.4B	14.8B	-6.00%	-14.25%	7.67	1.38	2.12%	209.17%
MID-CAP
ATR	9.5B	3.5B	-0.91%	22.96%	30.27	2.67	6.16%	35.06%
HSIC	9.4B	12.3B	-2.70%	-9.94%	22.59	0.76	-2.44%	-22.68%
BIO	8.1B	2.7B	-21.14%	-36.84%	-12.64	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.20%	-26.06%	-47.15	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-3.27%	17.57%	-560.12	9.28	33.86%	89.83%
PDCO	2.3B	6.6B	-7.27%	-4.94%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-12.41%	-15.32%	-1.95	0.41	7.73%	-1066.14%
ANIK	379.4M	166.7M	0.04%	-0.97%	-4.59	2.28	6.67%	-456.34%
ANGO	232.3M	324.0M	1.75%	-30.04%	-1.21	0.72	-3.19%	-337.41%
APYX	49.9M	52.3M	2.13%	-52.32%	-2.67	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-20.47%	240.00%	-0.29	0.95	5.77%	8.23%

Embecta Corp. News

Latest updates

Embecta Corp. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)														(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Revenue	-1.6%	277	282	286	277	276	275	291	275	289	301	295	284	285	-
Gross Profit	2.3%	186	182	190	190	189	177	203	191	204	210	203	196	191	-
Operating Expenses	-10.0%	140	156	138	134	100	180	106	92.00	87.00	93.00	78.00	70.00	67.00	-
S&GA Expenses	-5.6%	90.00	96.00	88.00	85.00	73.00	82.00	84.00	67.00	62.00	71.00	61.00	56.00	53.00	-
R&D Expenses	-14.4%	20.00	24.00	23.00	22.00	17.00	18.00	14.00	18.00	17.00	20.00	16.00	14.00	14.00	-
EBITDA Margin	-29.2%	0.09*	0.12*	0.09*	0.14*	0.20*	0.26*	0.38*	0.42*	0.45*	0.46*	0.46*	0.47*	0.47*	0.48*
Income Taxes	-480.0%	-5.80	-1.00	5.00	11.00	21.00	-10.30	11.00	14.00	18.00	20.00	20.00	21.00	20.00	-
Earnings Before Taxes	186.0%	14.00	5.00	20.00	25.00	56.00	-27.50	74.00	94.00	117	116	125	129	125	-
EBT Margin	-39.6%	0.06*	0.09*	0.07*	0.11*	0.18*	0.23*	0.35*	0.39*	0.42*	0.42*	0.42*	0.43*	0.44*	0.45*
Net Income	235.0%	20.00	6.00	15.00	14.00	35.00	-17.20	62.00	80.00	99.00	97.00	105	108	105	-
Net Income Margin	-21.6%	0.05*	0.06*	0.04*	0.08*	0.14*	0.20*	0.29*	0.33*	0.35*	0.36*	0.37*	0.38*	0.39*	0.39*
Free Cashflow	-177.5%	-15.80	20.00	-16.10	-18.80	56.00	49.00	28.00	177	135	73.00	122	115	110	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet										(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Assets	0.3%	1,218	1,214	1,252	1,210	1,197	1,086	1,050	834	740	788
Current Assets	-4.0%	720	749	788	756	762	665	581	427	258	292
Cash Equivalents	-8.5%	299	327	317	346	385	331	292	264	-	-
Inventory	-1.9%	149	152	170	158	143	123	130	122	119	118
Net PPE	-	-	-	-	-	-	-	-	356	437	451
Current Liabilities	-7.6%	327	354	386	358	370	301	229	169	159	164
Long Term Debt	-0.1%	1,593	1,594	1,595	1,596	1,597	1,598	1,599	1,404	-	-
LT Debt, Current	0%	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	-	-
LT Debt, Non Current	-0.1%	1,593	1,594	1,595	1,596	1,597	1,598	1,599	1,404	-	-
Shareholder's Equity	-	-	-	-	-	-	-	-	-	551	594
Retained Earnings	2.1%	-530	-541	-538	-545	-550	-577	-556	-	-	-
Additional Paid-In Capital	19.7%	33.00	28.00	23.00	18.00	13.00	10.00	6.00	-	-	-
Shares Outstanding	0.4%	58.00	57.00	57.00	57.00	57.00	57.00	58.00	58.00	-	-
Float	-	-	-	-	1,600	-	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	-144.3%	-13,100	29,600	-9,300	-13,000	60,400	58,000	32,800	182,600	138,800	85,500	129,700	119,700	121,400	-
Share Based Compensation	49.0%	7,300	4,900	5,300	5,800	5,500	4,400	5,800	3,900	4,600	3,200	2,900	2,900	3,800	-
Cashflow From Investing	70.7%	-2,700	-9,200	-6,800	-5,800	-4,700	-8,600	-5,300	-5,800	-4,300	-13,300	-7,700	-6,300	-11,900	-
Cashflow From Financing	-39.2%	-13,500	-9,700	-12,200	-20,700	-6,100	-7,100	3,300	90,300	-134,500	-72,200	-122,000	-113,400	-109,500	-
Dividend Payments	0%	8,600	8,600	8,600	17,200	-	8,600	-	-	-	-	-	-	-	-

EMBC Income Statement

2023-12-31

Condensed Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 277.3	$ 275.7
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Product [Member]	Product [Member]
Cost of products sold	$ 91.4	$ 86.9
Cost, Product and Service [Extensible Enumeration]	Product [Member]	Product [Member]
Gross Profit	$ 185.9	$ 188.8
Operating expenses:
Selling and administrative expense	90.3	72.8
Research and development expense	20.2	16.9
Other operating expenses	29.9	10.3
Total Operating Expenses	140.4	100.0
Operating Income	45.5	88.8
Interest expense, net	(27.7)	(25.6)
Other income (expense), net	(3.5)	(7.1)
Income Before Income Taxes	14.3	56.1
Income tax provision (benefit)	(5.8)	20.9
Net Income	$ 20.1	$ 35.2
Net Income per common share:
Basic (in dollars per share)	$ 0.35	$ 0.62
Diluted (in dollars per share)	$ 0.35	$ 0.61

EMBC Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Sep. 30, 2023
Current Assets
Cash and cash equivalents	$ 298.7	$ 326.5
Trade receivables, net (net of allowance for doubtful accounts of $1.2 million and $1.0 million as of December 31, 2023 and September 30, 2023, respectively)	96.1	16.7
Inventories:
Materials	32.9	32.1
Work in process	11.7	8.1
Finished products	104.6	111.9
Total Inventories	149.2	152.1
Amounts due from Becton, Dickinson and Company	110.3	142.4
Prepaid expenses and other	65.2	111.4
Total Current Assets	719.5	749.1
Property, Plant and Equipment, Net	301.3	300.2
Goodwill and Intangible Assets	24.3	24.7
Deferred Income Taxes and Other Assets	172.7	140.4
Total Assets	1,217.8	1,214.4
Current Liabilities
Accounts payable	42.1	53.5
Accrued expenses	122.2	118.1
Amounts due to Becton, Dickinson and Company	57.6	73.1
Salaries, wages and related items	57.4	62.1
Current debt obligations	9.5	9.5
Current finance lease liabilities	3.7	3.6
Income taxes	34.1	33.6
Total Current Liabilities	326.6	353.5
Deferred Income Taxes and Other Liabilities	60.7	57.2
Long-Term Debt	1,592.9	1,593.9
Non Current Finance Lease Liabilities	31.1	31.5
Commitments and Contingencies
Embecta Corp. Equity
Common stock, $0.01 par value Authorized - 250,000,000 Issued and outstanding - 57,573,497 as of December 31, 2023 and 57,333,353 as of September 30, 2023	0.6	0.6
Additional paid-in capital	33.4	27.9
Accumulated deficit	(530.0)	(541.1)
Accumulated other comprehensive loss	(297.5)	(309.1)
Total Equity	(793.5)	(821.7)
Total Liabilities and Equity	$ 1,217.8	$ 1,214.4

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

CEO	Mr. Devdatt Kurdikar
WEBSITE	embecta.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1900

Embecta Corp. Frequently Asked Questions

What is the ticker symbol for Embecta Corp.? What does EMBC stand for in stocks?

EMBC is the stock ticker symbol of Embecta Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Embecta Corp. (EMBC)?

As of Fri Apr 26 2024, market cap of Embecta Corp. is 593.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EMBC stock?

You can check EMBC's fair value in chart for subscribers.

What is the fair value of EMBC stock?

You can check EMBC's fair value in chart for subscribers. The fair value of Embecta Corp. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Embecta Corp. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EMBC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Embecta Corp. a good stock to buy?

The fair value guage provides a quick view whether EMBC is over valued or under valued. Whether Embecta Corp. is cheap or expensive depends on the assumptions which impact Embecta Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EMBC.

What is Embecta Corp.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, EMBC's PE ratio (Price to Earnings) is 10.72 and Price to Sales (PS) ratio is 0.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EMBC PE ratio will change depending on the future growth rate expectations of investors.